Patents Assigned to Curatis AG
  • Mirtazapine for use in medication overuse headache based on tension-type headache
    Patent number: 11207330
    Abstract: Mirtazapine is useful for the treatment and/or prophylaxis of medication overuse headache based on tension-type headache. Moreover, a pharmaceutical composition and/or the use of mirtazapine for the manufacture of a medicament, are useful against medication overuse headache based on tension-type headache, and the treatment of medication overuse headache based on tension-type headache.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: December 28, 2021
    Assignees: Curatis AG, Rigshospitalet—Glostrup, The University of Copenhagen
    Inventors: Arnim Pause, Lars Bendtsen, Rigmor Jensen, Jes Olesen
  • Dosage regimen for picotamide for the use in migraine
    Patent number: 11166946
    Abstract: Picotamide (4-methoxy-N,N?-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide, CAS-no. 32828-81-2) can be used in the treatment and/or prevention of migraine with aura. A specific dosage regimen is used in this treatment and/or prevention, where, in a first period, picotamide is administered for 2 to 6 months, and the first period is followed by a second period of 1 to 3 months without picotamide administration.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: November 9, 2021
    Assignee: CURATIS AG
    Inventor: Arnim Pause
  • DOSAGE REGIMEN FOR PICOTAMIDE FOR THE USE IN MIGRAINE
    Publication number: 20210069160
    Abstract: Picotamide (4-methoxy-N,N?-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide, CAS-no. 32828-81-2) can be used in the treatment and/or prevention of migraine with aura. A specific dosage regimen is used in this treatment and/or prevention, where, in a first period, picotamide is administered for 2 to 6 months, and the first period is followed by a second period of 1 to 3 months without picotamide administration.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Applicant: CURATIS AG
    Inventor: Arnim PAUSE
  • Mirtazapine for use in medication overuse headache based on tension-type headache
    Publication number: 20210015828
    Abstract: Mirtazapine is useful for the treatment and/or prophylaxis of medication overuse headache based on tension-type headache. Moreover, a pharmaceutical composition and/or the use of mirtazapine for the manufacture of a medicament, are useful against medication overuse headache based on tension-type headache, and the treatment of medication overuse headache based on tension-type headache.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicants: Curatis AG, Rigshospitalet - Glostrup, The University of Copenhagen
    Inventors: Arnim PAUSE, Lars Bendtsen, Rigmor Jensen, Jes Olesen